Mr. Lucas, some experts say that more could be approved if this measure were taken. What they say, and what is problematic, is that your criteria are too strict and inadequate, since rapid tests are compared to the PCR test. Instead, they should be assessed on their ability to identify infectious patients.
Why not increase their potential approval by changing the criteria and making them more accessible? It's all very well to say that 140 million rapid tests will be sent to us, but there could be more. This is important.
We spend money on antivirals. But if we don't have access to PCR tests, we can't use them effectively. There are other issues as well.